CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-10 | Murray Joshua M. Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-10 | WILSON JAMES N Director | Grant or award · Stock option (right to buy) | +25,000 | 25,000 | ||
| 2025-06-10 | Park Kimberly Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $14.08 | $31K | 2,200 |
| 2025-06-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $70.61 | $155K | 0 |
| 2025-06-10 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 9,900 | ||
| 2025-06-10 | Swisher Daniel N JR Director | Grant or award · Stock option (right to buy) 10b5-1 | +15,000 | 15,000 | ||
| 2025-06-10 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $21.65 | $433K | 25,487 |
| 2025-06-10 | Guyer William Chief Development Officer | Sale 10b5-1 | −16,918 | $72.36 | $1.2M | 8,569 |
| 2025-06-10 | Guyer William Chief Development Officer | Sale 10b5-1 | −3,082 | $72.75 | $224K | 5,487 |
| 2025-06-10 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 390,000 | ||
| 2025-06-10 | Alton Gregg H Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-10 | MAHONEY DAVID L Director | Grant or award · Stock option (right to buy) | +15,000 | 15,000 | ||
| 2025-06-03 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes 10b5-1 | −441 | $71.68 | $32K | 10,066 |
| 2025-06-03 | Robb Gary Charles Chief Business Officer | Shares withheld for taxes | −651 | $71.68 | $47K | 16,549 |
| 2025-06-03 | Mokari Atabak Chief Financial Officer | Shares withheld for taxes | −519 | $71.68 | $37K | 14,065 |
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −4,881 | $78.42 | $383K | 2,937,104 |
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −3,050 | $79.48 | $242K | 2,934,054 |
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −2,988 | $80.30 | $240K | 2,931,066 |
| 2025-06-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −1,820 | $81.33 | $148K | 2,929,246 |
Page 24 of 61 · 1,220 trades